Concepts (309)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patellofemoral Joint | 6 | 2020 | 129 | 2.900 |
Why?
|
Osteoarthritis, Knee | 11 | 2022 | 1226 | 2.550 |
Why?
|
Social Isolation | 14 | 2020 | 357 | 2.160 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 8 | 2018 | 898 | 1.730 |
Why?
|
Swimming | 14 | 2018 | 205 | 1.370 |
Why?
|
Antidepressive Agents | 12 | 2017 | 2886 | 1.280 |
Why?
|
Stress, Psychological | 16 | 2020 | 4378 | 1.070 |
Why?
|
Hindlimb Suspension | 3 | 2016 | 74 | 1.050 |
Why?
|
Patella | 4 | 2020 | 311 | 1.000 |
Why?
|
Osteophyte | 3 | 2019 | 44 | 0.980 |
Why?
|
Nitric Oxide | 11 | 2018 | 2113 | 0.930 |
Why?
|
Depression | 16 | 2018 | 7961 | 0.910 |
Why?
|
Cartilage, Articular | 3 | 2020 | 1091 | 0.900 |
Why?
|
Receptors, Opioid | 4 | 2016 | 145 | 0.880 |
Why?
|
Hand Joints | 2 | 2022 | 57 | 0.830 |
Why?
|
Indoles | 6 | 2017 | 1824 | 0.830 |
Why?
|
Narcotic Antagonists | 4 | 2018 | 570 | 0.780 |
Why?
|
Behavior, Animal | 13 | 2017 | 1856 | 0.760 |
Why?
|
Ulnar Neuropathies | 1 | 2020 | 32 | 0.720 |
Why?
|
Fractures, Closed | 1 | 2020 | 88 | 0.690 |
Why?
|
Exostoses | 1 | 2019 | 30 | 0.680 |
Why?
|
Osteoarthritis | 3 | 2022 | 1053 | 0.680 |
Why?
|
Hippocampus | 12 | 2020 | 3724 | 0.660 |
Why?
|
Magnetic Resonance Imaging | 14 | 2024 | 36042 | 0.630 |
Why?
|
Tibia | 3 | 2019 | 1060 | 0.630 |
Why?
|
Ondansetron | 2 | 2016 | 95 | 0.620 |
Why?
|
Ankle Joint | 1 | 2022 | 435 | 0.610 |
Why?
|
Cyclic GMP | 2 | 2016 | 396 | 0.600 |
Why?
|
Naltrexone | 6 | 2018 | 307 | 0.600 |
Why?
|
Pancreatitis, Chronic | 1 | 2020 | 280 | 0.570 |
Why?
|
Seizures | 10 | 2019 | 2922 | 0.560 |
Why?
|
Patellar Dislocation | 1 | 2017 | 66 | 0.540 |
Why?
|
Maternal Deprivation | 4 | 2017 | 47 | 0.540 |
Why?
|
Anti-Anxiety Agents | 2 | 2015 | 397 | 0.540 |
Why?
|
Serotonin Antagonists | 1 | 2016 | 144 | 0.510 |
Why?
|
Anxiety | 6 | 2018 | 4484 | 0.510 |
Why?
|
Nitric Oxide Synthase | 4 | 2018 | 909 | 0.500 |
Why?
|
Nitrites | 6 | 2018 | 158 | 0.490 |
Why?
|
Encephalitis | 2 | 2018 | 434 | 0.490 |
Why?
|
Nitrates | 1 | 2016 | 262 | 0.480 |
Why?
|
Lithium Compounds | 1 | 2015 | 224 | 0.460 |
Why?
|
Pentylenetetrazole | 7 | 2018 | 73 | 0.460 |
Why?
|
Edema | 1 | 2018 | 771 | 0.460 |
Why?
|
Pancreatitis | 1 | 2020 | 1100 | 0.430 |
Why?
|
Bone Marrow | 3 | 2022 | 2902 | 0.420 |
Why?
|
Fluoxetine | 2 | 2016 | 736 | 0.420 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2016 | 489 | 0.420 |
Why?
|
Diagnostic Errors | 1 | 2020 | 1248 | 0.410 |
Why?
|
Hip Fractures | 1 | 2020 | 987 | 0.400 |
Why?
|
Serotonin 5-HT3 Receptor Antagonists | 3 | 2016 | 23 | 0.390 |
Why?
|
Radiology | 3 | 2022 | 2097 | 0.390 |
Why?
|
Nicotine | 1 | 2015 | 676 | 0.360 |
Why?
|
Morphine | 6 | 2016 | 656 | 0.350 |
Why?
|
Cholestasis | 1 | 2013 | 374 | 0.350 |
Why?
|
Dizocilpine Maleate | 5 | 2018 | 172 | 0.350 |
Why?
|
Convulsants | 4 | 2018 | 71 | 0.340 |
Why?
|
Joint Instability | 1 | 2017 | 792 | 0.340 |
Why?
|
Four-Dimensional Computed Tomography | 2 | 2022 | 148 | 0.330 |
Why?
|
Disease Management | 1 | 2020 | 2484 | 0.330 |
Why?
|
Cartilage Diseases | 2 | 2022 | 156 | 0.330 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1683 | 0.320 |
Why?
|
Bone and Bones | 1 | 2019 | 2551 | 0.310 |
Why?
|
Anticonvulsants | 5 | 2019 | 1894 | 0.310 |
Why?
|
Oxidative Stress | 2 | 2016 | 3062 | 0.310 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3322 | 0.300 |
Why?
|
Mitochondria | 6 | 2019 | 3574 | 0.300 |
Why?
|
Mice | 36 | 2020 | 80745 | 0.300 |
Why?
|
Anxiety Disorders | 2 | 2015 | 2706 | 0.290 |
Why?
|
Male | 53 | 2024 | 356577 | 0.280 |
Why?
|
Dose-Response Relationship, Drug | 11 | 2019 | 10811 | 0.280 |
Why?
|
Cartilage | 2 | 2020 | 807 | 0.280 |
Why?
|
Electroshock | 2 | 2018 | 123 | 0.280 |
Why?
|
NG-Nitroarginine Methyl Ester | 3 | 2016 | 259 | 0.270 |
Why?
|
Knee Joint | 5 | 2022 | 1653 | 0.260 |
Why?
|
Adipose Tissue | 1 | 2018 | 3290 | 0.260 |
Why?
|
Amphetamine | 2 | 2018 | 224 | 0.260 |
Why?
|
Receptors, Opioid, mu | 2 | 2018 | 163 | 0.260 |
Why?
|
Motor Activity | 5 | 2016 | 2682 | 0.260 |
Why?
|
Cyclohexanecarboxylic Acids | 2 | 2017 | 139 | 0.260 |
Why?
|
Receptor, Cannabinoid, CB1 | 2 | 2017 | 139 | 0.250 |
Why?
|
Disease Progression | 8 | 2022 | 13427 | 0.250 |
Why?
|
Enzyme Inhibitors | 8 | 2018 | 3728 | 0.250 |
Why?
|
Excitatory Amino Acid Antagonists | 3 | 2016 | 448 | 0.250 |
Why?
|
Animals | 42 | 2020 | 167149 | 0.240 |
Why?
|
Crohn Disease | 1 | 2017 | 2266 | 0.240 |
Why?
|
Amines | 2 | 2017 | 280 | 0.240 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4295 | 0.230 |
Why?
|
Prostatic Neoplasms | 2 | 2024 | 11312 | 0.230 |
Why?
|
Depressive Disorder | 2 | 2016 | 3731 | 0.230 |
Why?
|
Exploratory Behavior | 4 | 2018 | 273 | 0.210 |
Why?
|
Oxytocin | 2 | 2017 | 396 | 0.210 |
Why?
|
Serotonin | 3 | 2016 | 1031 | 0.210 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5286 | 0.200 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2018 | 623 | 0.200 |
Why?
|
Pruritus | 2 | 2015 | 366 | 0.200 |
Why?
|
Disease Models, Animal | 16 | 2018 | 18027 | 0.200 |
Why?
|
Radiography | 4 | 2022 | 6975 | 0.190 |
Why?
|
Collateral Ligaments | 1 | 2021 | 34 | 0.190 |
Why?
|
Elbow | 1 | 2020 | 130 | 0.180 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2017 | 1130 | 0.170 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5731 | 0.170 |
Why?
|
Locomotion | 3 | 2018 | 385 | 0.170 |
Why?
|
Humans | 36 | 2024 | 755533 | 0.170 |
Why?
|
Rheumatic Nodule | 1 | 2018 | 2 | 0.160 |
Why?
|
Quality-Adjusted Life Years | 3 | 2020 | 1713 | 0.160 |
Why?
|
Receptors, Opioid, delta | 1 | 2018 | 44 | 0.160 |
Why?
|
Internship and Residency | 1 | 2019 | 5831 | 0.160 |
Why?
|
Central Nervous System Stimulants | 2 | 2018 | 1164 | 0.160 |
Why?
|
Reactive Oxygen Species | 2 | 2016 | 2106 | 0.150 |
Why?
|
Receptors, Opioid, kappa | 1 | 2018 | 138 | 0.150 |
Why?
|
Silver | 1 | 2018 | 119 | 0.150 |
Why?
|
Child Mortality | 1 | 2019 | 204 | 0.140 |
Why?
|
Prostate-Specific Antigen | 2 | 2024 | 2525 | 0.140 |
Why?
|
Wrist Joint | 1 | 2019 | 264 | 0.140 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2017 | 49 | 0.140 |
Why?
|
Benzenesulfonates | 1 | 2017 | 164 | 0.140 |
Why?
|
Minocycline | 1 | 2018 | 169 | 0.140 |
Why?
|
Nitrosation | 1 | 2016 | 24 | 0.140 |
Why?
|
Selegiline | 1 | 2016 | 31 | 0.140 |
Why?
|
Drug Inverse Agonism | 1 | 2016 | 11 | 0.130 |
Why?
|
Animals, Newborn | 3 | 2016 | 2667 | 0.130 |
Why?
|
Receptors, Histamine H1 | 1 | 2015 | 19 | 0.130 |
Why?
|
Receptors, Histamine H3 | 1 | 2015 | 11 | 0.130 |
Why?
|
Potassium Channels | 1 | 2019 | 536 | 0.130 |
Why?
|
Patients | 1 | 2022 | 904 | 0.130 |
Why?
|
Lithium Chloride | 1 | 2016 | 82 | 0.130 |
Why?
|
Endorphins | 1 | 2015 | 74 | 0.130 |
Why?
|
Evaluation Studies as Topic | 1 | 2018 | 1635 | 0.130 |
Why?
|
Anxiety, Separation | 1 | 2015 | 86 | 0.130 |
Why?
|
Rubidium | 1 | 2015 | 122 | 0.130 |
Why?
|
Propensity Score | 2 | 2022 | 1903 | 0.130 |
Why?
|
Prostate | 1 | 2024 | 1784 | 0.130 |
Why?
|
Antipruritics | 1 | 2015 | 31 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 4 | 2020 | 20404 | 0.130 |
Why?
|
Capsaicin | 1 | 2016 | 231 | 0.130 |
Why?
|
Cytotoxins | 1 | 2016 | 152 | 0.130 |
Why?
|
Elasticity Imaging Techniques | 1 | 2020 | 384 | 0.130 |
Why?
|
Biopsy | 2 | 2024 | 6760 | 0.120 |
Why?
|
Receptors, Serotonin, 5-HT3 | 1 | 2015 | 44 | 0.120 |
Why?
|
Immunity, Innate | 2 | 2018 | 3036 | 0.120 |
Why?
|
Nitrogen Oxides | 1 | 2015 | 128 | 0.120 |
Why?
|
Corticosterone | 1 | 2015 | 303 | 0.120 |
Why?
|
Arginine | 2 | 2018 | 934 | 0.120 |
Why?
|
Sympathectomy | 1 | 2015 | 90 | 0.120 |
Why?
|
Infant Mortality | 1 | 2019 | 750 | 0.120 |
Why?
|
Receptors, Dopamine D1 | 1 | 2016 | 292 | 0.120 |
Why?
|
Motivation | 4 | 2018 | 1991 | 0.120 |
Why?
|
Immobilization | 1 | 2015 | 230 | 0.120 |
Why?
|
Female | 19 | 2022 | 387920 | 0.120 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 934 | 0.120 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25696 | 0.120 |
Why?
|
Oxides | 1 | 2016 | 401 | 0.120 |
Why?
|
Toll-Like Receptors | 1 | 2017 | 591 | 0.120 |
Why?
|
Middle Aged | 12 | 2024 | 218055 | 0.110 |
Why?
|
Piperidines | 3 | 2018 | 1644 | 0.110 |
Why?
|
N-Methylaspartate | 1 | 2014 | 230 | 0.110 |
Why?
|
Metal Nanoparticles | 1 | 2018 | 400 | 0.110 |
Why?
|
Receptors, Dopamine D2 | 1 | 2016 | 483 | 0.110 |
Why?
|
Lithium | 1 | 2016 | 595 | 0.110 |
Why?
|
Patient Satisfaction | 2 | 2022 | 3440 | 0.110 |
Why?
|
Renal Artery | 1 | 2015 | 366 | 0.110 |
Why?
|
Interleukin-1beta | 2 | 2016 | 998 | 0.110 |
Why?
|
Disabled Persons | 2 | 2020 | 1222 | 0.110 |
Why?
|
Mitochondrial Diseases | 1 | 2017 | 342 | 0.110 |
Why?
|
Physical Examination | 1 | 2019 | 1240 | 0.110 |
Why?
|
Embryonic Stem Cells | 1 | 2020 | 1268 | 0.110 |
Why?
|
Femur | 1 | 2019 | 1290 | 0.110 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14383 | 0.110 |
Why?
|
Pain Threshold | 1 | 2016 | 597 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 1988 | 0.100 |
Why?
|
Chlorides | 1 | 2015 | 666 | 0.100 |
Why?
|
Pituitary-Adrenal System | 1 | 2015 | 550 | 0.100 |
Why?
|
PPAR gamma | 1 | 2015 | 485 | 0.100 |
Why?
|
Ligation | 1 | 2013 | 449 | 0.100 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2017 | 2414 | 0.100 |
Why?
|
Pyrazoles | 3 | 2018 | 1985 | 0.100 |
Why?
|
Bile Ducts | 1 | 2013 | 285 | 0.100 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2015 | 699 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1874 | 0.100 |
Why?
|
Artifacts | 1 | 2020 | 1893 | 0.090 |
Why?
|
Feasibility Studies | 2 | 2019 | 5180 | 0.090 |
Why?
|
Maternal Exposure | 1 | 2018 | 1029 | 0.090 |
Why?
|
Headache | 1 | 2019 | 1238 | 0.090 |
Why?
|
ROC Curve | 1 | 2018 | 3553 | 0.090 |
Why?
|
Ultrasonography | 2 | 2021 | 5937 | 0.090 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15746 | 0.090 |
Why?
|
Foot | 1 | 2014 | 572 | 0.090 |
Why?
|
Analgesics, Opioid | 5 | 2018 | 3719 | 0.080 |
Why?
|
Aged | 7 | 2024 | 167376 | 0.080 |
Why?
|
Mood Disorders | 1 | 2016 | 1121 | 0.080 |
Why?
|
Colitis | 1 | 2017 | 1222 | 0.080 |
Why?
|
Ethanol | 1 | 2015 | 1329 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2503 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2016 | 1394 | 0.080 |
Why?
|
Prognosis | 2 | 2020 | 29423 | 0.080 |
Why?
|
Colon | 1 | 2016 | 1789 | 0.080 |
Why?
|
Radiography, Interventional | 1 | 2015 | 1118 | 0.070 |
Why?
|
Fractures, Bone | 1 | 2020 | 2024 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12926 | 0.070 |
Why?
|
Inflammation | 2 | 2017 | 10717 | 0.070 |
Why?
|
Vasotocin | 2 | 2017 | 10 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2447 | 0.070 |
Why?
|
Myocytes, Cardiac | 1 | 2016 | 1646 | 0.070 |
Why?
|
Internet | 1 | 2019 | 3073 | 0.070 |
Why?
|
Hormone Antagonists | 2 | 2017 | 108 | 0.070 |
Why?
|
Migraine Disorders | 1 | 2019 | 1664 | 0.070 |
Why?
|
Decision Making | 1 | 2020 | 3898 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2020 | 2478 | 0.070 |
Why?
|
Nitric Oxide Synthase Type I | 2 | 2016 | 172 | 0.060 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2470 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14636 | 0.060 |
Why?
|
Maze Learning | 2 | 2017 | 478 | 0.060 |
Why?
|
Cardiomyopathies | 1 | 2016 | 1932 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 2510 | 0.060 |
Why?
|
Time Factors | 4 | 2018 | 39961 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4558 | 0.060 |
Why?
|
Signal Transduction | 4 | 2018 | 23278 | 0.050 |
Why?
|
Pain | 1 | 2016 | 4999 | 0.050 |
Why?
|
Brain | 3 | 2018 | 26737 | 0.050 |
Why?
|
Metacarpophalangeal Joint | 1 | 2021 | 82 | 0.040 |
Why?
|
Risk Factors | 3 | 2024 | 73860 | 0.040 |
Why?
|
Ontario | 1 | 2021 | 401 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2024 | 79686 | 0.040 |
Why?
|
Kidney | 1 | 2015 | 7009 | 0.040 |
Why?
|
Disease Susceptibility | 2 | 2017 | 1774 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7774 | 0.040 |
Why?
|
United Nations | 1 | 2019 | 152 | 0.040 |
Why?
|
Thumb | 1 | 2021 | 230 | 0.040 |
Why?
|
Receptors, Cannabinoid | 1 | 2018 | 43 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9452 | 0.040 |
Why?
|
Computer Systems | 1 | 2020 | 472 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2018 | 6237 | 0.040 |
Why?
|
State Medicine | 1 | 2020 | 210 | 0.040 |
Why?
|
Quality of Life | 1 | 2020 | 13201 | 0.040 |
Why?
|
Body Weight | 2 | 2021 | 4606 | 0.040 |
Why?
|
Finger Joint | 1 | 2018 | 108 | 0.040 |
Why?
|
Organizational Objectives | 1 | 2019 | 428 | 0.040 |
Why?
|
Geography | 1 | 2019 | 661 | 0.040 |
Why?
|
Incidence | 3 | 2020 | 21239 | 0.030 |
Why?
|
Phospholipases A2 | 1 | 2016 | 197 | 0.030 |
Why?
|
Streptozocin | 1 | 2016 | 193 | 0.030 |
Why?
|
Immobility Response, Tonic | 1 | 2016 | 13 | 0.030 |
Why?
|
Grooming | 1 | 2016 | 37 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39179 | 0.030 |
Why?
|
Naphthalenes | 1 | 2017 | 191 | 0.030 |
Why?
|
Histamine Agonists | 1 | 2015 | 13 | 0.030 |
Why?
|
Nitric Oxide Donors | 1 | 2016 | 125 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15651 | 0.030 |
Why?
|
Brazil | 1 | 2020 | 1193 | 0.030 |
Why?
|
Arsenicals | 1 | 2016 | 115 | 0.030 |
Why?
|
Radiology Information Systems | 1 | 2020 | 525 | 0.030 |
Why?
|
Benzoxazines | 1 | 2017 | 309 | 0.030 |
Why?
|
Histamine Antagonists | 1 | 2015 | 92 | 0.030 |
Why?
|
Dopamine Agents | 1 | 2016 | 189 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58549 | 0.030 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2016 | 103 | 0.030 |
Why?
|
Guanylate Cyclase | 1 | 2016 | 205 | 0.030 |
Why?
|
TRPV Cation Channels | 1 | 2016 | 242 | 0.030 |
Why?
|
Random Allocation | 1 | 2019 | 2390 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2121 | 0.030 |
Why?
|
Indazoles | 1 | 2016 | 293 | 0.030 |
Why?
|
Restraint, Physical | 1 | 2015 | 186 | 0.030 |
Why?
|
Morpholines | 1 | 2017 | 587 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2016 | 600 | 0.030 |
Why?
|
Cytosol | 1 | 2016 | 885 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1822 | 0.030 |
Why?
|
Observer Variation | 1 | 2019 | 2593 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3407 | 0.030 |
Why?
|
Life Expectancy | 1 | 2020 | 1248 | 0.030 |
Why?
|
Food Preferences | 1 | 2016 | 398 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2016 | 579 | 0.030 |
Why?
|
Sheep | 1 | 2015 | 1437 | 0.030 |
Why?
|
Age Factors | 2 | 2022 | 18366 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2016 | 1841 | 0.030 |
Why?
|
Housing | 1 | 2017 | 664 | 0.030 |
Why?
|
Aggression | 1 | 2017 | 743 | 0.030 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 956 | 0.020 |
Why?
|
beta Catenin | 1 | 2016 | 1043 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 21887 | 0.020 |
Why?
|
Adult | 3 | 2019 | 217986 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2846 | 0.020 |
Why?
|
Ketamine | 1 | 2016 | 508 | 0.020 |
Why?
|
Self Care | 1 | 2015 | 789 | 0.020 |
Why?
|
Models, Animal | 1 | 2015 | 2117 | 0.020 |
Why?
|
Sex Factors | 1 | 2022 | 10493 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15197 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 6121 | 0.020 |
Why?
|
Public Health | 1 | 2019 | 2656 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7782 | 0.020 |
Why?
|
Pain Measurement | 1 | 2015 | 3468 | 0.020 |
Why?
|
Pregnancy | 2 | 2018 | 29543 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4344 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10392 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12500 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2020 | 4678 | 0.010 |
Why?
|
Heart | 1 | 2016 | 4387 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15589 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 23956 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10538 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15647 | 0.010 |
Why?
|
Skin | 1 | 2015 | 4445 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 87236 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 12753 | 0.010 |
Why?
|
Rats | 1 | 2016 | 23588 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 26039 | 0.010 |
Why?
|
Infant | 1 | 2019 | 35867 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 58025 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64535 | 0.010 |
Why?
|
Child | 1 | 2019 | 79427 | 0.010 |
Why?
|
Concepts
(309)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_